Devices and Diagnostics

Keeping the MIGS Explosion in Perspective

Keeping the MIGS Explosion in Perspective

By Karen Blum | June 13, 2018

WASHINGTON, DC – When Stanford University ophthalmology professor Kuldev Singh, MD, MPH, underwent medical training 25 years ago, there were maybe five to six non-pharmaceutical…

Read More
Takeaways from OIS@ASCRS 2018

15 Things We Learned at OIS@ASCRS

By Rich Kirkner | April 20, 2018

Here are 15 takeaways from last week’s OIS@ASCRS 2018. Barry Cheskin of PowerVision reported on a pilot study of 27 patients who had the FluidVision…

Read More
41 Things On Tap at OIS@ASCRS

41 Things On Tap at OIS@ASCRS

By Rich Kirkner | April 4, 2018

There are 41 different sessions, panels, and presentations happening at OIS@ASCRS 2018 – including five different breakout sessions on everything from dry eye to emerging…

Read More
Can ODs Take Over Ocular Surface Disease?

Will ODs Take Over Ocular Surface Disease Treatment?

By Tom Salemi | March 9, 2018

Over the past decade, the treatment of ocular surface conditions such as dry eye and meibomian gland dysfunction (MGD) has evolved from “pats on the…

Read More
Why ReVision Optics Shut Down

A Look Behind ReVision Optics’ Shuttered Door

By Larry Haimovitch | February 14, 2018

By Larry Haimovitch and Richard Mark Kirkner Someday for some company, the business of selling corneal inlays to treat presbyopia could be very lucrative, but…

Read More
With CE Mark for Glaucoma Microsensor in Pocket, Implandata Looks to US

With CE Mark for Glaucoma Microsensor in Pocket, Implandata Looks to US

By Rich Kirkner | June 21, 2017

Now that the Implandata Ophthalmic Products has received approval to commercialize its implantable glaucoma-monitoring device in the European Union, it’s setting its sights on lining…

Read More
How Mynosys Is Gearing Up to Take on Femto

How Mynosys is Gearing Up to Take on Femto

By Rich Kirkner | June 14, 2017

Now that Mynosys Cellular Devices has received FDA 510(k) clearance for its Zepto Capsulotomy System for cataract surgery, the company is planning its US launch…

Read More

What’s Behind the Heat-up in Glaucoma Innovation

By Larry Haimovitch | February 22, 2017

Kicking off the sixth annual Glaucoma 360-New Horizons Forum held recently in San Francisco, co-founder and co-chair Adrienne Graves boldly proclaimed, “Glaucoma is hot.” However,…

Read More

Is DR Just the Start for Google Brain?

By Steve Lenier | February 9, 2017

A team of investigators recently reported online in the Journal of the American Medical Association1 that a Google algorithm allows computers to diagnose diabetic retinopathy…

Read More
part-two-three-novel-partnerships-11-30-16

Three Novel Partnerships in Ophthalmology (Part Two)

By Michael Smolinsky | November 30, 2016

Two weeks ago, we began reviewing collaborations between ophthalmic start-ups and institutions or groups that traditionally haven’t been involved in developing medical technology, such as…

Read More
Corneal Inlays Garnering Attention – and Investment - Eye On Innovation Article - Healthegy

Corneal Inlays Garnering Attention – & Investment

By Larry Haimovitch | November 1, 2016

Recent positive reports about two FDA-approved corneal inlays may yet give this market sector a boost heading into 2017. Irvine, CA-based AcuFocus was the first…

Read More

Mazzo: Retina Remains the “Biggest Frontier”

By Tom Salemi | August 3, 2016

In this week’s OIS Podcast, we spoke with Jim Mazzo, the head of Carl Zeiss Meditec’s new ophthalmology unit. In the podcast, Mazzo hits upon…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.